Details

Autor(en) / Beteiligte

• Bartlett, Edmund K., MD
• Karakousis, Giorgos C., MD

Titel

Current Staging and Prognostic Factors in Melanoma

Ist Teil von

• Surgical oncology clinics of North America, 2015-04, Vol.24 (2), p.215-227

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2015

Quelle

MEDLINE

Beschreibungen/Notizen

• The current American Joint Commission for Cancer staging system for melanoma includes thickness, ulceration, and mitotic index as primary tumor factors for patients with stage I and II disease. Number and size of nodal metastases, presence of satellitosis and in-transit disease, and tumor ulceration status categorize patients with stage III disease. Presence and location of distant metastatic disease and increased lactate dehydrogenase level stratify prognosis in patients with stage IV disease. Factors predictive of sentinel lymph node positivity are also studied, particularly in patients with T1 melanomas, but are not always congruent with those predictive of survival.